Recombinant Francisella tularensis subsp. mediasiatica GMP synthase [glutamine-hydrolyzing] (guaA), partial

What is GMP synthase [glutamine-hydrolyzing] and what is its function in F. tularensis?

GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) is a critical amidotransferase enzyme that catalyzes the amination of xanthosine 5'-monophosphate (XMP) to form guanosine monophosphate (GMP). This reaction occurs in the presence of glutamine and ATP, where glutamine hydrolysis provides the necessary amino group while ATP hydrolysis drives the reaction. The enzyme can also utilize ammonia as an alternative amino group donor under certain conditions. In F. tularensis, this enzyme plays a crucial role in purine biosynthesis, which is essential for bacterial survival and virulence .

The enzyme contains two functional domains that operate in a coordinated manner: the glutaminase domain (responsible for glutamine hydrolysis) and the synthetase domain (responsible for ATP hydrolysis and GMP formation). These domains work in concert during normal catalytic activity but can be uncoupled under specific inhibitory conditions .

How does F. tularensis subsp. mediasiatica differ from other F. tularensis subspecies?

Francisella tularensis subspecies mediasiatica is one of four recognized subspecies of F. tularensis, alongside subsp. tularensis (Type A), subsp. holarctica (Type B), and subsp. novicida. F. tularensis subsp. mediasiatica is considered a select agent like subsp. tularensis and holarctica, whereas subsp. novicida is not classified as a select agent .

The genome of F. tularensis subsp. mediasiatica, like other select agent subspecies, contains a duplicated Francisella pathogenicity island (FPI) and numerous insertion sequence (IS) elements. This genomic structure differs significantly from the opportunistic F. tularensis subsp. novicida, which contains only a single FPI and few IS elements . These genomic differences contribute to variations in virulence and host adaptation among the subspecies.

What is the molecular structure of GMP synthase from F. tularensis subsp. mediasiatica?

GMP synthase from F. tularensis subsp. mediasiatica (strain FSC147) is encoded by the guaA gene and corresponds to UniProt accession number B2SGK4. The recombinant partial protein preserves the critical functional domains required for its enzymatic activity. The protein has two primary domains: the glutaminase domain containing the glutamine amide transfer function and the synthetase domain responsible for ATP binding and XMP amination .

A key feature of the glutaminase domain is the presence of a conserved cysteine residue (equivalent to Cys104 in human GMP synthetase) that is critical for glutamine hydrolysis. This residue is the target of inhibitors like acivicin, which covalently modify this site and selectively abolish glutaminase activity without affecting the synthetase activity when ammonia is used as an alternative substrate .

What are the optimal storage and reconstitution conditions for recombinant F. tularensis GMP synthase?

For optimal stability and activity of recombinant Francisella tularensis subsp. mediasiatica GMP synthase, the protein should be stored at -20°C for standard storage, or at -80°C for extended preservation. Prior to use, it is recommended to briefly centrifuge the storage vial to ensure the contents settle at the bottom .

For reconstitution, the following protocol is recommended:

• Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (standard recommendation is 50%)

• Aliquot the reconstituted protein to avoid repeated freeze-thaw cycles

• Store working aliquots at 4°C for up to one week

• Store long-term aliquots at -20°C/-80°C

The shelf life of the reconstituted protein in liquid form is approximately 6 months when stored at -20°C/-80°C, while the lyophilized form has a shelf life of approximately 12 months under the same storage conditions .

What assay methods can be used to measure GMP synthase activity in F. tularensis samples?

GMP synthase activity can be assessed through several complementary approaches:

• Coupled Enzymatic Assay: This approach measures the conversion of XMP to GMP by monitoring the consumption of ATP or production of AMP. The reaction can be coupled to additional enzymes that produce a detectable signal (colorimetric, fluorescent, or luminescent) proportional to the activity of GMP synthase.

• Glutamine Hydrolysis Assay: Since GMP synthase hydrolyzes glutamine to produce glutamate and ammonia, the production of glutamate can be monitored using glutamate dehydrogenase and measuring NADH formation spectrophotometrically.

• Acivicin Inhibition Assay: The differential response to acivicin can be used to distinguish between glutamine-dependent and ammonia-dependent activities. Acivicin selectively inhibits the glutaminase activity, allowing researchers to separately assess the two functional domains of the enzyme .

• Pyrophosphate Inhibition Assay: Inorganic pyrophosphate inhibits the synthetase domain and uncouples the two domain functions, allowing glutamine hydrolysis to occur without ATP hydrolysis or GMP formation. This property can be exploited to study domain coordination .

How can one design experiments to study the role of GMP synthase in F. tularensis virulence?

Designing experiments to investigate the role of GMP synthase in F. tularensis virulence requires a multi-faceted approach:

• Creation of guaA Knockout Mutants: Generate defined deletion mutants of the guaA gene in F. tularensis using allelic exchange techniques. This approach would be similar to the methodology used for generating trpB mutants in F. tularensis studies, where the gene's contribution to bacterial survival and virulence was assessed .

• Complementation Studies: Reintroduce the wild-type guaA gene to confirm that any observed phenotypes are specifically due to the loss of GMP synthase activity rather than polar effects on adjacent genes.

• Intracellular Growth Assays: Assess the ability of wild-type and guaA mutant strains to survive and replicate within host macrophages, both in the presence and absence of IFN-γ stimulation. This would indicate whether GMP synthase, like tryptophan prototrophy, contributes to resisting IFN-γ-mediated host defense mechanisms .

• Mouse Infection Models: Evaluate the virulence of guaA mutants in both wild-type and IFN-γ receptor-deficient (IFN-γR −/−) mice to determine if IFN-γ-mediated signaling contributes to clearance of guaA mutants, similar to observations with trpB mutants .

• Substrate Availability Studies: Investigate whether host cells restrict guanine nucleotide availability as a defense mechanism against F. tularensis, similar to how tryptophan is depleted via IFN-γ-induced indoleamine 2,3-dioxygenase (IDO) .

How does inhibition of GMP synthase affect F. tularensis survival within activated macrophages?

Inhibition of GMP synthase likely impairs F. tularensis survival within activated macrophages through mechanisms similar to those observed with tryptophan auxotrophs. When macrophages are activated by IFN-γ, they initiate numerous antimicrobial mechanisms, including the restriction of essential nutrients like amino acids and nucleotide precursors .

Based on research with tryptophan auxotrophs, we can predict that GMP synthase inhibition would have the following effects:

• Restricted Growth in Nutrient-Limited Environments: GMP synthase-deficient strains would be unable to synthesize GMP de novo, making them dependent on exogenous guanine nucleotides. When these nutrients become limited in activated macrophages, bacterial replication would be significantly impaired.

• Differential Survival in IFN-γ-Treated vs. Untreated Macrophages: Similar to trpB mutants, guaA mutants would likely show normal or near-normal replication in untreated macrophages (where nutrients are more abundant) but significantly reduced survival in IFN-γ-treated macrophages .

• Strain-Specific Differences: Based on the differences observed between F. tularensis subsp. novicida and F. tularensis subsp. tularensis trpB mutants, we might expect different F. tularensis subspecies to show varying degrees of attenuation when GMP synthase is inhibited .

What are the structural differences between human and F. tularensis GMP synthase that could be exploited for selective inhibition?

Several structural differences between human and F. tularensis GMP synthase could potentially be exploited for selective inhibition:

• Catalytic Site Residues: While the active site cysteine (equivalent to Cys104 in human GMP synthetase) is conserved, surrounding residues may differ between the human and bacterial enzymes, potentially allowing for the design of selective inhibitors .

• Domain Architecture: Although both human and bacterial GMP synthases contain glutaminase and synthetase domains, the interdomain regions and specific domain arrangements may differ, offering potential sites for selective targeting.

• Allosteric Regulation Sites: Differences in allosteric regulation and binding of modulatory molecules between human and bacterial enzymes could provide opportunities for selective inhibition.

• Protein-Protein Interactions: F. tularensis GMP synthase may engage in species-specific protein-protein interactions within the bacterial cell that could be disrupted by appropriately designed inhibitors.

A comparative analysis of crystal structures or homology models of human and F. tularensis GMP synthases would be required to identify specific residues or structural features that could be targeted for selective inhibition.

How does domain coordination in GMP synthase contribute to F. tularensis pathogenesis?

Domain coordination in GMP synthase likely plays a crucial role in F. tularensis pathogenesis through several mechanisms:

• Metabolic Efficiency: The coordinated action of the glutaminase and synthetase domains ensures efficient conversion of glutamine and XMP to GMP, optimizing energy utilization during intracellular replication when resources may be limited .

• Regulatory Control: The coordinated domains allow for precise regulation of GMP synthesis in response to changing environmental conditions within the host, ensuring appropriate allocation of resources during different stages of infection.

• Substrate Channeling: Coordinated domains may facilitate substrate channeling, where the ammonia produced by glutamine hydrolysis is directly transferred to the synthetase active site without release into solution. This would prevent the loss of ammonia and increase catalytic efficiency, particularly important in nutrient-restricted environments .

• Response to Host Defense Mechanisms: Domain coordination may allow F. tularensis to rapidly adapt its nucleotide metabolism in response to host defense mechanisms that target purines, similar to how tryptophan prototrophy helps the bacterium evade IFN-γ-mediated tryptophan restriction .

How can qPCR assays be optimized for accurate identification of F. tularensis subsp. mediasiatica?

Optimizing qPCR assays for accurate identification of F. tularensis subsp. mediasiatica requires several key considerations:

• Target Selection: Select genomic targets unique to F. tularensis subsp. mediasiatica that differentiate it from other subspecies (tularensis, holarctica, and novicida) and near neighbors like Francisella philomiragia, Francisella persica, and Francisella-like endosymbionts .

• Primer and Probe Design: Design primers and hydrolysis probes that specifically amplify and detect these unique regions. The use of fluorescence-based singleplex or non-matrix scoring multiplex qPCR assays utilizing hydrolysis probes provides sensitive and specific F. tularensis subspecies identification .

• Validation with Reference Strains: Validate the assay using well-characterized reference strains of all F. tularensis subspecies and near neighbors to confirm specificity.

• Sequencing Confirmation: Implement sequencing of the amplified targets to provide clade confirmation and strain-specific details, enhancing the diagnostic capability of the assay .

• Control Strategy: Include appropriate positive controls (genomic DNA from reference strains), negative controls (non-template controls), and internal amplification controls to monitor for PCR inhibition.

The development of such optimized qPCR assays would facilitate accurate identification and differentiation of F. tularensis subsp. mediasiatica during epidemiological investigations and for research purposes .

What genomic markers best differentiate F. tularensis subsp. mediasiatica from other subspecies?

Several genomic markers can effectively differentiate F. tularensis subsp. mediasiatica from other subspecies:

• Francisella Pathogenicity Island (FPI): F. tularensis subsp. mediasiatica, like other select agent subspecies (tularensis and holarctica), contains a duplicated FPI, distinguishing it from subsp. novicida which has only a single copy .

• Insertion Sequence (IS) Elements: The presence and distribution pattern of IS elements can differentiate subsp. mediasiatica from other subspecies. Select agent subspecies typically contain numerous IS elements compared to the few present in subsp. novicida .

• Subspecies-Specific SNPs: Single nucleotide polymorphisms in conserved genes can serve as reliable markers for subspecies identification.

• Metabolic Gene Variations: Differences in genes encoding metabolic functions, including nucleotide biosynthesis genes like guaA, can provide additional markers for differentiation.

The table below summarizes key genomic features differentiating F. tularensis subspecies:

By targeting these differentiating features, researchers can accurately identify and classify F. tularensis subsp. mediasiatica in complex samples .

How does inhibition of GMP synthase compare to inhibition of other biosynthetic pathways in F. tularensis?

Comparative analysis of biosynthetic pathway inhibition in F. tularensis reveals distinct patterns of attenuation:

What methodological approaches can be used to study the kinetics of the glutaminase and synthetase domains separately?

Several methodological approaches enable the separate study of glutaminase and synthetase domain kinetics in GMP synthase:

• Domain Uncoupling with Pyrophosphate: Inorganic pyrophosphate inhibits the synthetase domain while allowing the glutaminase function to proceed independently. This property can be exploited to study the glutaminase domain in isolation by adding pyrophosphate to the reaction mixture and monitoring glutamine hydrolysis without GMP formation .

• Selective Inhibition with Acivicin: Acivicin, a glutamine analog, selectively abolishes the glutaminase activity without affecting the synthetase activity when ammonia is used as the amino donor. This allows researchers to study the synthetase domain independently by using ammonia as the nitrogen source in the presence of acivicin .

• Domain-Specific Mutations: Introducing site-directed mutations at key residues specific to each domain can selectively impair one function while preserving the other. For example, mutation of the conserved cysteine (equivalent to Cys104 in human GMP synthetase) would specifically impair glutamine hydrolysis without directly affecting ATP binding or XMP amination .

• Recombinant Expression of Individual Domains: Separately expressing and purifying the individual domains allows direct study of their kinetic properties in isolation, though this approach may not capture important interdomain interactions.

These complementary approaches provide a comprehensive toolkit for dissecting the complex kinetic behavior of this bifunctional enzyme and understanding how coordination between domains contributes to catalytic efficiency.

How can structural knowledge of F. tularensis GMP synthase inform vaccine development strategies?

Structural knowledge of F. tularensis GMP synthase can inform vaccine development through several approaches:

• Attenuated Strain Development: Understanding the structural basis of GMP synthase function can guide the development of rationally attenuated F. tularensis strains with defined mutations in guaA. Similar to the approach with trpB mutants, guaA mutants could potentially serve as live attenuated vaccine candidates that retain immunogenicity while demonstrating reduced virulence .

• Epitope Identification: Structural analysis can identify surface-exposed, immunogenic epitopes on GMP synthase that might serve as components of subunit vaccines. Additionally, regions that are conserved across F. tularensis subspecies but different from human GMP synthase would be particularly valuable targets.

• Adjuvant Development: Knowledge of how GMP synthase components interact with host immune receptors could inform the development of adjuvants that enhance immune responses to F. tularensis antigens.

• Cross-Protective Immunity: If structural studies reveal conserved regions across different F. tularensis subspecies, these could be targeted to develop vaccines that provide cross-protection against multiple subspecies.

• Structure-Based Immunomodulation: Understanding the structural basis of how GMP synthase contributes to immune evasion could lead to strategies for modulating the immune response to enhance protection while minimizing harmful inflammation.

What are the most promising approaches for developing selective inhibitors of F. tularensis GMP synthase?

Development of selective inhibitors targeting F. tularensis GMP synthase could proceed through several complementary approaches:

• Active Site-Directed Inhibitors: Design compounds that selectively target the glutaminase active site, particularly the conserved cysteine residue (equivalent to Cys104 in human GMP synthetase) that is critical for glutamine hydrolysis. Acivicin provides a starting point for such development, as it covalently modifies this residue .

• Allosteric Modulators: Identify binding sites unique to the bacterial enzyme that could be targeted by small molecules to disrupt domain coordination or induce conformational changes that inhibit enzymatic activity.

• Transition State Analogs: Design compounds that mimic the transition state of the reaction catalyzed by either the glutaminase or synthetase domain, focusing on structural features unique to the bacterial enzyme.

• Fragment-Based Drug Design: Identify small molecular fragments that bind weakly to different regions of the bacterial enzyme and link or optimize them to create potent, selective inhibitors.

• Computer-Aided Drug Design: Utilize computational approaches including molecular docking, virtual screening, and molecular dynamics simulations to identify and optimize lead compounds with selective activity against the bacterial enzyme.

• Natural Product Screening: Screen libraries of natural products for compounds with selective activity against F. tularensis GMP synthase, which could serve as starting points for further optimization.

The most promising inhibitors would target features unique to the bacterial enzyme, demonstrate selective toxicity against F. tularensis over host cells, and maintain activity under the environmental conditions encountered during infection.

How can systems biology approaches integrate GMP synthase function into broader metabolic networks of F. tularensis?

Systems biology approaches offer powerful tools for understanding GMP synthase within the broader context of F. tularensis metabolism:

These approaches would provide a comprehensive understanding of how GMP synthase function is integrated into the broader metabolic capabilities that enable F. tularensis to survive and replicate within host cells, potentially revealing novel therapeutic strategies.